James Cullen - Agilent Technologies Independent Non-Executive Chairman of the Board

A -- USA Stock  

Earnings Call  This Week

  Chairman
Mr. James G. Cullen is no longer NonExecutive Independent Director of Agilent Technologies, Inc., effective March 21, 2018. Mr. Cullen was President and Chief Operating Officer of Bell Atlantic Corporationrationration from 1997 to June 2000 and a member of the office of chairman from 1993 to June 2000. Prior to this appointment, Mr. Cullen was the President and Chief Executive Officer of the Telecom Group of Bell Atlantic from 1995 to 1997. Prior to the creation of Bell Atlantic on January 1, 1984, Mr. Cullen held management positions with New Jersey Bell from 1966 to 1981 and ATT from 1981 to 1983.
Age: 72  Chairman Since 2017      
408-345-8886  http://www.agilent.com

James Cullen Latest Insider Activity

Management Efficiency

The company has return on total asset of 0.09 % which means that for every 100 dollars spent on asset it generated profit of $0.09. This is way below average. Similarly, it shows return on equity (ROE) of 0.17 % implying that it made 0.17 on every $100 invested by shareholders.
The company has accumulated 1.8 B in total debt with debt to equity ratio (D/E) of 37.8 implying that the company may be unable to produce cash to meet its debt commitments. Agilent Technologies has Current Ratio of 2.09 implying that it is liquid and has the capability to pay out its interest payments when they become due.

Similar Executives

Found 11 records

CHAIRMAN Since

Ting ZhengGlobal Cord Blood Corporation
2018
Kevin ConroyExact Sciences Corporation
2014
Erez RaphaelDarioHealth Corp
2018
Yuen KamGlobal Cord Blood Corporation
2012
Willis LeeEmmaus Life Sciences
2019
David KingLaboratory Corporation Of Ameri
2019
Jonathan LordDexCom
2015
Yoav ShakedDarioHealth Corp
2018
Yutaka NiiharaEmmaus Life Sciences
2019
Samuel ColellaFluidigm Corporation
2000
Terrance GreggDexCom
2015

Entity Summary

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Medical Laboratories Research classification in USA and is traded on BATS Exchange. It employs 15700 people.Agilent Technologies (A) is traded on BATS Exchange in USA. It is located in 5301 Stevens Creek Boulevard and employs 15,700 people. Agilent Technologies is listed under Measuring and Control Equipment category by Fama And French industry classification.

Agilent Technologies Leadership Team

Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, President, Life Sciences and Applied Markets Group
Samraat Raha, Senior Vice President, President, Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President and Presidentident - Order Fulfillment
Dow Wilson, Independent Director
Heidi Kunz, Independent Director
Dominique Grau, Senior Vice President - Human Resources
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Boon Koh, Independent Chairman of the Board
Robert Herbold, Independent Director

Stock Performance Indicators

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Agilent Technologies Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Agilent Technologies and Global Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.
Search macroaxis.com